Cargando…
Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression
Overexpression of histone deacetylases (HDACs) in cancer commonly causes resistance to genotoxic-based therapies. Here, we report on the novel mechanism whereby overexpressed class I HDACs increase the resistance of glioblastoma cells to the S(N)1 methylating agent temozolomide (TMZ). The chemothera...
Autores principales: | Hanisch, Daniela, Krumm, Andrea, Diehl, Tamara, Stork, Carla M., Dejung, Mario, Butter, Falk, Kim, Ella, Brenner, Walburgis, Fritz, Gerhard, Hofmann, Thomas G., Roos, Wynand P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975953/ https://www.ncbi.nlm.nih.gov/pubmed/35365623 http://dx.doi.org/10.1038/s41419-022-04751-7 |
Ejemplares similares
-
B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells
por: Roos, Wynand P., et al.
Publicado: (2014) -
The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracil
por: Kiweler, Nicole, et al.
Publicado: (2022) -
Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs
por: Quiros, Steve, et al.
Publicado: (2011) -
The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair
por: Roos, Wynand Paul, et al.
Publicado: (2016) -
The nuclear proteome of Trypanosoma brucei
por: Goos, Carina, et al.
Publicado: (2017)